American College of Cardiology (ACC)

See the following -

Before The Prescription, Ask About Your Doctor's Finances

Leana Wen | Capital Public Radio | December 16, 2013

At the dawn of managed care, worried patients wanted to know whether their doctors were getting paid more to do less. Now, as many doctors' salaries depend on how many procedures they perform, patients want to know whether their doctors are paid more to do more. Read More »

Don’t Give More Patients Statins

John D. Abramson and Rita F. Redberg | New York Times | November 13, 2013

ON Tuesday, the American Heart Association and the American College of Cardiology issued new cholesterol guidelines that essentially declared, in one fell swoop, that millions of healthy Americans should immediately start taking pills — namely statins — for undefined health “benefits.” Read More »

How Clinical Guidelines Can Fail Both Doctors And Patients

Robert McNutt and Nortin Hadler | The Health Care Blog | December 11, 2013

Any confusion over the recent news of cholesterol guidelines in the U.S. is perfectly understandable. On the one hand, the guidelines suggest that nearly half the population should use statins to stave off heart attacks and strokes. On the other, use of the drugs is not with potential side effects and, to many, will offer no substantive benefits. [...] Read More »

NIST Funds Secure Online Healthcare Transactions Pilot

Mary Mosquera | Government Health IT | September 21, 2012

The National Institute of Standards and Technology has awarded $9 million in grants to five collaborative groups, including one for healthcare exchange, to demonstrate how online transactions can be secure and private as part of the National Strategy for Trusted Identities in Cyberspace. Read More »

The Statinization Of America

Vik Khanna, Tom Emerick and Al Lewis | The Health Care Blog | November 14, 2013

On November 12, 2013, the American Heart Association (AHA) and the American College of Cardiology (ACC) disrupted the cardiovascular disease (CVD) universe by issuing four new guidelines.  The guidelines depart from past efforts because the relevant federal agency, the National Heart, Lung, and Blood Institute (NHBLI), did not lead development.  NHBLI now ‘sponsors’ guideline development, but has deferred actual writing and publication to private groups. Read More »